Table 3

Effectiveness of surgery in relation to diabetes resolution

VariableGroup; no. (%) of patients*
LSG
n = 7
LRYGB
n = 4
Sex
 Male1 (14)0 (0)
 Female6 (86)4 (100)
Age, mean (SE), yr43.0 (8.6)54.5 (16.5)
Baseline BMI, mean (SE)33.7 (0.44)33.2 (1.29)
Preoperative oral hypoglycemic therapy6 (86)1 (25)
 Postoperative cessation3 (50)0 (0)
 Postoperative reduction3 (50)1 (100)
Preoperative insulin therapy1 (14)3 (75)
 Postoperative cessation1 (100)1 (33)
 Postoperative reduction0 (0)1 (33)
Preoperative HbA1c level, mean (SE), %7.6 (1.09)7.7 (1.55)
5-yr postoperative HbA1c level, mean (SE), %6.0 (0.006)6.7 (0.01)
Postoperative diabetes status
 Complete remission3 (43)1 (25)
 Glycemic control3 (43)1 (25)
 No improvement0 (0)1 (25)
 Missing data1 (14)1 (25)
  • BMI = body mass index; HbA1c = glycosylated hemoglobin; LRYGB = laparoscopic Roux-en-Y gastric bypass; LSG = laparoscopic sleeve gastrectomy; SE = standard error.

  • * Except where noted otherwise.

  • One patient was lost to follow-up.